|
| View:
Latest News | Top Stories |
|
| 1.
|
Ahead of the Bell: PerkinElmer
-
AP
-
Fri 9:53 am ET
PerkinElmer Inc. is focusing on areas that will lead to significantly higher profits starting in 2011, an analyst said as he upgraded the stock to "Hold" from "Sell" and raised his earnings expectations for the health and industrial sciences company through 2011.
|
|
| 2.
|
Covidien says it is recalling blood dye lot
-
AP
-
Fri 7:54 am ET
Covidien PLC said Friday it has recalled one production lot of a radiopharmaceutical dye used to test red blood cell levels because the product was not as potent as it should have been.
|
|
| 3.
|
DexCom Appoints Eric Topol, M.D. as Board Member
-
Business Wire
-
Thu 5:13 pm ET
SAN DIEGO----DexCom, Inc. today announced the appointment of Eric Topol, M.D. as a member of DexCom's Board of Directors.
|
|
| 4.
|
TranS1 Inc. Pre-Announces Q2 2009 Revenues
-
GlobeNewswire
-
Thu 2:03 pm ET
|
|
| 5.
|
XTENT, Inc. Announces That It Has Postponed the Special Meeting of Its Stockholders
-
PR Newswire
-
Tue Jul 7
XTENT, Inc. today announced that it has postponed its special meeting of stockholders which was scheduled to take place at 9:00 a.m. Pacific Time on Thursday, July 9, 2009.
|
|
| 6.
|
Baxter International Second Quarter 2009 Financial Results Conference Call
-
Business Wire
-
Mon Jul 6
DEERFIELD, Ill.----Baxter International , will host a quarterly conference call to discuss its second quarter 2009 financial results on Thursday, July 16, 2009, at 8:30 a.m. Eastern Time .
|
|
| 7.
|
Nephros Receives 510k Approval for Dual Stage Ultrafilters
-
PR Newswire
-
Thu Jul 2
Nephros, Inc. , a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today reported that is has received 510k approval from the U.S.
|
|
| 8.
|
Luminex Corporation Announces Executive Appointments
-
Business Wire
-
Wed Jun 24
AUSTIN, Texas----Luminex Corporation , the worldwide leader in multiplexed solutions, today announced three executive appointments, all effective July 1, 2009.
|
|
| 9.
|
Second U.S. Independent Laboratory Confirms that Oculus Innovative Sciences' MicrocynŽ Technology Effective at Inactivating H1N1 Swine Flu
-
Business Wire
-
Wed Jun 24
PETALUMA, Calif.----Oculus Innovative Sciences, Inc. , a healthcare company that develops, manufactures and markets a family of products based upon the MicrocynŽ Technology platform, which includes new formulations intended to reduce the use of antibiotics by preventing or treating infections including those caused by bacteria and viruses, has confirmed the effectiveness of MicrocynŽ Technology at inactivating the H1NI Swine Influenza A.
|
|
| 10.
|
China Medical adjusted 4Q profit tops estimates
-
AP
-
Fri Jun 19
Medical-device maker China Medical Technologies Inc. said Friday its adjusted profit from continuing operations grew 43 percent in the fiscal fourth quarter.
|
|
